RNAemia and Severe COVID-19: Candidate Treatment Targets Identified Through Transcriptomics.
Host gene expression changes associated with RNAemia, particularly involving OLAH, PCSK9, and ADAMTS2, had stronger statistical evidence of severe outcomes than RNAemia itself, and PCSK9 is an intervenable treatment target worth further study.